The Caledonian-Record

Annovis Provides Corporate Updates and Reports Fiscal Year 2025 Financial Results

Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a Phase 3 clinical-stage biotechnology company developing the investigational oral therapy, buntanetap, for ...